Stoke Therapeutics Inc (STOK)

Cost of Revenue

$4.23M

TTM · Period ending: · USD

STOK logo

STOK Cost of Revenue

Latest reported$4.23M
STOK TTM Cost of Revenue ($0.00 → $4.23M)
High-resolution chart · PNG

STOK cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Stoke Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
4,228,999
3,090,999
2,044,000
989,000
0
1,110,000
2,223,000
3,438,000
4,638,000
4,695,000
4,729,000
4,666,000
4,390,000
4,058,000
3,535,000
2,383,000
1,459,000
624,000
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.